Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

MacroGenics and Servier enter into license agreement for MGA-271

Dec. 2, 2011

Curis and the Leukemia and Lymphoma Society agree to develop CUDC-907

Dec. 2, 2011

Medunik Canada acquires Canadian rights to two orphan therapies from QOL Medical

Dec. 2, 2011

Dainippon Sumitomo Pharma and Yoshitomiyakuhin to terminate antipsychotic drug copromotion agreement

Dec. 1, 2011

Idera Pharmaceuticals regains global rights to IMO-2055

Dec. 1, 2011

Companies collaborate on spinal muscular atrophy research

Dec. 1, 2011

OncoVista secures CRO for phase Ib study of cordycepin

Nov. 30, 2011

Infinity and Mundipharma extend strategic alliance for PI3K inhibitors

Nov. 30, 2011

Compugen and DiscoveRx collaborate on novel peptide ligands

Nov. 30, 2011

Proximagen and Altacor enter agreement for serotonin 5-HT2C program

Nov. 30, 2011

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...